Related references
Note: Only part of the references are listed.Pediatric influenza and illness severity: what is known and what questions remain?
Joshua D. Doyle et al.
CURRENT OPINION IN PEDIATRICS (2019)
Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients
Essack Mitha et al.
INFECTIOUS DISEASES AND THERAPY (2019)
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials
Ryan E. Malosh et al.
CLINICAL INFECTIOUS DISEASES (2018)
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
Adam Meijer et al.
ANTIVIRAL RESEARCH (2011)
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
Ken M. Kunisaki et al.
LANCET INFECTIOUS DISEASES (2009)
Recovery of drug-resistant influenza virus from immunocompromised patients: A case series
MG Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy
WG Nichols et al.
CLINICAL INFECTIOUS DISEASES (2004)
Canadian Acute Respiratory Illness and Flu Scale (CARIFS): Development of a valid measure for childhood respiratory infections
B Jacobs et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
